Grey Wolf Therapeutics’ $49 Million Series B Funding Round

Goodwin Procter advised Grey Wolf Therapeutics on the deal, while DLA Piper advised Pfizer Ventures and Earlybird Venture Capital.Grey Wolf Therapeutics announced its $49 million Series B funding…

This content is for Standard 1 Year members only.
Login Join Now
Martina Bellini

Author: Martina Bellini

This content is for Standard 1 Year members only.
Login Join Now